Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in Berlin, Germany. This
Dr. Ronald Vender discusses TKY2 Inhibitors and explains their contribution to the initiation and chronicity of psoriasis.
Dr. Lluis Puig moderates a panel discussion with experts Richard Warren and Ronald Vender, covering section three lectures.
Review the approval of intravenous spesolimab for generalized pustular psoriasis (GPP) treatment by regulatory authorities. Gain valuable insights from a
Access insights on patient adherence in psoriasis treatments, covering evolving therapies, oral agents, biologics, and phototherapy. Real-world data highlights the
Dr. Ulrich Mrowietz explores the evolving concept of psoriatic disease, diverse treatment targets, and the significance of personalized care.
Dr. Catherine Smith discusses the science and practice, framework, and implementation of therapeutic drug monitoring (TDM).
Dr. Johann Gudjonsson explores psoriasis as a complex genetic condition involving diverse immune and stromal cell populations with cytokine interactions.
Dr. Alexis Ogdie explores the potential of psoriasis treatment in either delaying or preventing the onset of psoriatic arthritis.
Dr. Mahira El-Sayed discusses the therapeutic challenges related to diagnosing and treating psoriasis in patients with skin of color.
